Legal status · United States
Is Idebenone legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Idebenone is not an approved medicine in the United States; its classification is "Not approved; sold in cosmetics and supplements". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 5 human studies are cited on its profile.
Idebenone in the United States at a glance
| Classification | Not approved; sold in cosmetics and supplements |
|---|---|
| Note | No FDA approval for any indication. Idebenone appears in topical antioxidant skincare and in oral nootropic products sold without approval for a medical use. |
| FDA approval status | Not FDA approved for any indication. Authorised in the European Union as Raxone for Leber hereditary optic neuropathy since September 2015, under exceptional circumstances. Separately sold in topical skincare and in oral nootropic supplements, neither of which is an approved use. |
| Human studies cited | 5 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Idebenone profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Idebenone is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Idebenone is
Authorised in the European Union for one rare mitochondrial optic neuropathy, granted under exceptional circumstances because the normal evidence standard was not met. The randomised trial that supported it missed its primary endpoint, and the trials in Alzheimer's disease and Friedreich ataxia were negative.
Idebenone is three separate products wearing one name, and they should not be read as supporting each other. The medicine.
Mechanism: A short-chain benzoquinone that can accept electrons from cytosolic NAD(P)H quinone dehydrogenase 1 and deliver them to complex III, bypassing a defective complex I. That is a coherent rationale for a disease caused by complex I mutations, which is what Leber hereditary optic neuropathy is, and it is why the drug found its indication there rather than in general antioxidant use.
Regulatory history: Not FDA approved for any indication. Authorised in the European Union as Raxone for Leber hereditary optic neuropathy since September 2015, under exceptional circumstances. Separately sold in topical skincare and in oral nootropic supplements, neither of which is an approved use.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Idebenone at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Idebenone in other countries
Frequently asked questions
Is Idebenone legal in the United States?
No. Idebenone is not an approved medicine in the United States; its classification is "Not approved; sold in cosmetics and supplements". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 5 human studies are cited on its profile. Note: No FDA approval for any indication. Idebenone appears in topical antioxidant skincare and in oral nootropic products sold without approval for a medical use.
Can I buy Idebenone in the United States?
No approved product exists to buy. In the United States Idebenone is classified as "Not approved; sold in cosmetics and supplements", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: No FDA approval for any indication. Idebenone appears in topical antioxidant skincare and in oral nootropic products sold without approval for a medical use.
Is Idebenone FDA approved?
No. FDA status: Not FDA approved for any indication. Authorised in the European Union as Raxone for Leber hereditary optic neuropathy since September 2015, under exceptional circumstances. Separately sold in topical skincare and in oral nootropic supplements, neither of which is an approved use.. Current US classification: "Not approved; sold in cosmetics and supplements". On the evidence, 5 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Idebenone live on its compound profile.
Idebenone profileThis page is general information about the regulatory status of Idebenone in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.